Natera’s Non-Invasive Prenatal Diagnostic to Detect Down Syndrome, Trisomy 13, Trisomy 18 and Certain Sex Chromosome Abnormalities in the First Trimester of Pregnancy

2/3/2012 7:01:24 AM

REDWOOD CITY, Calif.--(BUSINESS WIRE)--Natera, formerly known as Gene Security Network, today announced that details about the breadth of the company’s non-invasive prenatal diagnostic test will be disclosed in presentations during the Society for Maternal-Fetal Medicine’s 32nd Annual Meeting, February 6-11, in Dallas.

Read at BioSpace.com

Read Article at

Related Companies

News Categories

• BioSpace.com

• Diagnostics

• Medical Dev. & Diag. - Events